2,000
Participants
Start Date
February 28, 2026
Primary Completion Date
September 30, 2032
Study Completion Date
September 30, 2032
defibrillation lead
This is a device registry for the OmniaSecure™ defibrillation lead. The OmniaSecure lead is a steroid eluting, integrated bipolar, nonretractable screw-in, catheter delivered, transvenous ventricular lead with a Right Ventricular (RV) defibrillation coil electrode. The lead is designed for pacing, sensing, cardioversion, and defibrillation therapies, and has application for patients whom transvenous ICDs and cardiac resynchronization therapy defibrillators (CRT-Ds) are indicated.
Northwell Health South Shore University Hospital, Bay Shore
Lehigh Valley Health Network, Allentown
Pennsylvania Hospital, Philadelphia
University of Virginia Medical Center, Charlottesville
Vanderbilt University Medical Center, Nashville
Cleveland Clinic Foundation, Cleveland
Minneapolis Heart Institute Foundation, Minneapolis
Washington University School of Medicine, St Louis
Saint Lukes Health System, Kansas City
Texas Cardiac Arrhythmia Research Foundation, Austin
Presbyterian Heart Group, Albuquerque
Hartford Hosptial, Hartford
Virtua Health, Marlton
Lead Sponsor
Medtronic
INDUSTRY